Multiple Sclerosis Trial, By Invitation NCT06873464 Sponsor: European University of Madrid Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT06873464
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with multiple sclerosis according to a specific standard set of diagnostic guidelines called the McDonald criteria (2017 revised version).
  • People who are between 18 and 75 years of age.
  • People who have not had a relapse (a flare-up of MS symptoms) in the last 2 months.
  • People who have been experiencing fatigue in the last 6 months, measured as scoring above 4 on a standard fatigue questionnaire called the Fatigue Severity Scale.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose medication treatment has not been stable for at least the past month.
  • People for whom the brain stimulation technique used in this trial (called tDCS) would not be safe, such as those with a defibrillator, pacemaker, brain stimulator, implanted metal in the skull, skull fractures or cracks, damaged skin or recent scars in the treatment area, epilepsy, or pregnancy.
  • People who are receiving or are due to receive certain MS immune-suppressing medications — specifically Ocrelizumab, Rituximab, Lemtrada, or Mavenclad — within one week before or during the brain stimulation sessions.
  • People who have cognitive difficulties that would prevent them from understanding the questionnaires used in the trial.
  • People who experience negative side effects from the brain stimulation treatment (tDCS) used in this trial.
  • People who are unable to remain in the study long enough to complete the third treatment cycle and/or the final assessment visit.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
European University of Madrid
Registry
ClinicalTrials.gov
Start date
20 February 2025
Est. completion
31 July 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Fatigue Impact

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov